| Quantitative assessment of the heterogeneity of PD-L1 expression in non–small-cell lung cancer J McLaughlin, G Han, KA Schalper, D Carvajal-Hausdorf, V Pelekanou, ... JAMA oncology 2 (1), 46-54, 2016 | 859 | 2016 |
| A prospective, multi-institutional, pathologist-based assessment of 4 immunohistochemistry assays for PD-L1 expression in non–small cell lung cancer DL Rimm, G Han, JM Taube, SY Eunhee, JA Bridge, DB Flieder, R Homer, ... JAMA oncology 3 (8), 1051-1058, 2017 | 752 | 2017 |
| Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors JR Strosberg, A Cheema, J Weber, G Han, D Coppola, LK Kvols Journal of Clinical Oncology 29 (22), 3044-3049, 2011 | 297 | 2011 |
| Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer JA Rehman, G Han, DE Carvajal-Hausdorf, BE Wasserman, V Pelekanou, ... Modern Pathology 30 (3), 340-349, 2017 | 173 | 2017 |
| Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung R Baker, G Han, S Sarangkasiri, ML DeMarco, C Turke, CW Stevens, ... International Journal of Radiation Oncology* Biology* Physics 85 (1), 190-195, 2013 | 162 | 2013 |
| “Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy E Torlakovic, HJ Lim, J Adam, P Barnes, G Bigras, AWH Chan, ... Modern Pathology 33 (1), 4-17, 2020 | 159 | 2020 |
| Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications JR Strosberg, A Cheema, JM Weber, M Ghayouri, G Han, PJ Hodul, ... Annals of surgery 256 (2), 321-325, 2012 | 159 | 2012 |
| A phase II study of RO4929097 in metastatic colorectal cancer JR Strosberg, T Yeatman, J Weber, D Coppola, MJ Schell, G Han, ... European journal of cancer 48 (7), 997-1003, 2012 | 140 | 2012 |
| Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies … ST Mahmood, S Agresta, CE Vigil, X Zhao, G Han, G D'Amato, CE Calitri, ... International journal of cancer 129 (8), 1963-1969, 2011 | 137 | 2011 |
| Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer ES Reisenbichler, G Han, A Bellizzi, V Bossuyt, J Brock, K Cole, O Fadare, ... Modern pathology 33 (9), 1746-1752, 2020 | 107 | 2020 |
| Clinical characteristics and outcomes for solitary fibrous tumor (SFT): a single center experience N DeVito, E Henderson, G Han, D Reed, MM Bui, R Lavey, L Robinson, ... PLoS One 10 (10), e0140362, 2015 | 103 | 2015 |
| Prediction for computer experiments having quantitative and qualitative input variables G Han, TJ Santner, WI Notz, DL Bartel Technometrics 51 (3), 278-288, 2009 | 98 | 2009 |
| The unique clinical characteristics of melanoma diagnosed in children D Han, JS Zager, G Han, SS Marzban, CA Puleo, AA Sarnaik, D Reed, ... Annals of surgical oncology 19, 3888-3895, 2012 | 92 | 2012 |
| Analysis of overdispersed count data: application to the Human Papillomavirus Infection in Men (HIM) Study JH Lee, G Han, WJ Fulp, AR Giuliano Epidemiology & Infection 140 (6), 1087-1094, 2012 | 88 | 2012 |
| Simultaneous determination of tuning and calibration parameters for computer experiments G Han, TJ Santner, JJ Rawlinson Technometrics 51 (4), 464-474, 2009 | 71 | 2009 |
| Osteosarcoma in pediatric patients and young adults: a single institution retrospective review of presentation, therapy, and outcome CL Haddox, G Han, L Anijar, O Binitie, GD Letson, MM Bui, DR Reed Sarcoma 2014, 2014 | 66 | 2014 |
| A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors JR Strosberg, JM Weber, J Choi, TL Campos, TL Valone, G Han, ... Annals of oncology 23 (9), 2335-2341, 2012 | 63 | 2012 |
| Consequences of axillary ultrasound in patients with T2 or greater invasive breast cancers MC Lee, J Eatrides, A Chau, G Han, JV Kiluk, N Khakpour, CE Cox, ... Indian Journal of Surgical Oncology 2, 159-164, 2011 | 61 | 2011 |
| Loss of antigenicity with tissue age in breast cancer SE Combs, G Han, N Mani, S Beruti, M Nerenberg, DL Rimm Laboratory investigation 96 (3), 264-269, 2016 | 54 | 2016 |
| ERβ splice variant expression in four large cohorts of human breast cancer patient tumors H Wimberly, G Han, D Pinnaduwage, LC Murphy, XR Yang, IL Andrulis, ... Breast cancer research and treatment 146, 657-667, 2014 | 53 | 2014 |
David RimmYale UniversityVerified email at yale.edu
